Aurora Cannabis (ACB) Stock Price, News & Analysis

Company Overview

Aurora Cannabis Inc. (NASDAQ: ACB) is a Canadian licensed producer of medical and consumer cannabis products headquartered in Edmonton, Alberta. Established in 2013, the company operates under Health Canada’s regulations to cultivate, process and distribute a range of cannabis-based offerings. Since its initial public listing in 2017, Aurora has grown into one of the country’s largest growers by cultivation capacity and production output.

The company’s core business spans the cultivation of dried flower, the extraction of cannabis oils and the development of value-added products such as softgels, capsules and topical treatments. Aurora serves both the medical market—with products distributed through physicians and pharmacies—and the adult‐use market in jurisdictions where recreational cannabis is legal. Its portfolio includes proprietary genetics and branded offerings designed to deliver consistent cannabinoid and terpene profiles.

Aurora operates several state-of-the-art production facilities, including high-tech greenhouses and indoor cultivation sites, most notably the Aurora Sky campus near Edmonton. The company holds EU Good Manufacturing Practice (GMP) certification, enabling exports to key European markets such as Germany, Italy and Denmark, and maintains partnerships in Latin America, Australia and parts of the Asia Pacific region. Through strategic investments and acquisition of international distribution platforms, Aurora seeks to extend its reach into emerging cannabis markets.

Leadership at Aurora Cannabis has evolved since its founding, with Chairman and Chief Executive Officer Miguel Martin overseeing a shift toward operational efficiency and product innovation. The company’s early leadership team included co-founders Terry Booth and Steve Dobler, who guided initial expansion and public-market entry. Aurora has also pursued notable acquisitions—such as MedReleaf in 2018—to bolster production capacity and diversify its product mix. Looking ahead, Aurora aims to leverage its research capabilities and global infrastructure to capture growth opportunities in both medical and adult-use cannabis sectors.

Key Stats

• Today's Range: $4.96 to $4.96
• 50-Day Range: $4.21 to $5.62
• 52-Week Range: $3.42 to $6.91
• Volume: 20,734 shs
• Average Volume: 1.84 million shs
• Market Capitalization: $278.86 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Buy

Aurora Cannabis Stock Analysis - MarketRank™

Aurora Cannabis scored higher than 11% of companies evaluated by MarketBeat, and ranked 916th out of 947 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Aurora Cannabis.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: -4.35%

Earnings Growth

Earnings for Aurora Cannabis are expected to decrease by -4.35% in the coming year, from $0.46 to $0.44 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Aurora Cannabis is -25.85, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Aurora Cannabis is -25.85, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Aurora Cannabis has a P/B Ratio of 0.63. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

10.69% of the float of Aurora Cannabis has been sold short.

Short Interest Ratio / Days to Cover

Aurora Cannabis has a short interest ratio ("days to cover") of 3.9, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Aurora Cannabis has recently increased by 1.86%, indicating that investor sentiment is decreasing.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Aurora Cannabis does not currently pay a dividend.

Dividend Growth

Aurora Cannabis does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

10.69% of the float of Aurora Cannabis has been sold short.

Short Interest Ratio / Days to Cover

Aurora Cannabis has a short interest ratio ("days to cover") of 3.9, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Aurora Cannabis has recently increased by 1.86%, indicating that investor sentiment is decreasing.

News and Social Media

• Score: 2.7 / 5
• News Sentiment: 0.92

News Sentiment

Aurora Cannabis has a news sentiment score of 0.92. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.

News Coverage This Week

MarketBeat has tracked 4 news articles for Aurora Cannabis this week, compared to 3 articles on an average week.

Search Interest

Only 7 people have searched for ACB on MarketBeat in the last 30 days. This is a decrease of -30% compared to the previous 30 days.

MarketBeat Follows

11 people have added Aurora Cannabis to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 0.8 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Aurora Cannabis insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 0.01% of the stock of Aurora Cannabis is held by insiders.

Percentage Held by Institutions

47.63% of the stock of Aurora Cannabis is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

ACB Stock Analysis - Frequently Asked Questions

How have ACB shares performed this year?

Aurora Cannabis' stock was trading at $4.25 at the start of the year. Since then, ACB shares have increased by 16.2% and is now trading at $4.94.

How were Aurora Cannabis' earnings last quarter?

Aurora Cannabis Inc. (NASDAQ:ACB) posted its earnings results on Wednesday, August, 6th. The company reported ($0.19) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.18 by $0.37. The company had revenue of $71.98 million for the quarter, compared to analysts' expectations of $96.83 million. Aurora Cannabis had a negative net margin of 5.66% and a negative trailing twelve-month return on equity of 1.49%.
Read the conference call transcript.

When did Aurora Cannabis' stock split?

Aurora Cannabis shares reverse split on the morning of Tuesday, February 20th 2024.The 1-10 reverse split was announced on Tuesday, February 20th 2024. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, February 20th 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Does Aurora Cannabis have any subsidiaries?

Aurora Cannabis subsidiaries include these companies: Reliva LLC, Whistler Medical Marijuana Corporation, ICC Labs Inc., Anandia Labs Inc, MedReleaf Corp., CanniMed Therapeutics Inc., Larssen Ltd, and others.

Who are Aurora Cannabis' major shareholders?

Aurora Cannabis' top institutional shareholders include Tidal Investments LLC (2.67%), Walleye Trading LLC, Group One Trading LLC and Sculptor Capital LP.

How do I buy shares of Aurora Cannabis?

Shares of ACB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Aurora Cannabis own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Aurora Cannabis investors own include Canopy Growth (CGC), Cronos Group (CRON), NVIDIA (NVDA), Meta Platforms (META), Humana (HUM), Marinus Pharmaceuticals (MRNS) and American Water Works (AWK).

Company Calendar

• Last Earnings: 8/06/2025
• Today: 9/12/2025
• Next Earnings (Estimated): 11/05/2025
• Fiscal Year End: 3/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED PRODUCTS
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:ACB
• Previous Symbol: NYSE:ACB
• CIK: 1683541
• Web: auroramj.com
• Phone: (855) 279-4652
• Fax: N/A
• Employees: 1,130
• Year Founded: 2006

Profitability

• EPS (Trailing Twelve Months): ($0.19)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 10.72
• P/E Growth: N/A
• Net Income: $1.63 million
• Net Margins: -5.66%
• Pretax Margin: -1.91%
• Return on Equity: -1.49%
• Return on Assets: -1.06%

Debt

• Debt-to-Equity Ratio: 0.06
• Current Ratio: 2.97
• Quick Ratio: 1.51

Sales & Book Value

• Annual Sales: $246.72 million
• Price / Sales: 1.13
• Cash Flow: $0.61 per share
• Price / Cash Flow: 8.13
• Book Value: $7.78 per share
• Price / Book: 0.63

Miscellaneous

• Outstanding Shares: 56,450,000
• Free Float: 56,448,000
• Market Cap: $278.30 million
• Optionable: Optionable
• Beta: 1.91